ERIS Lifesciences Ltd.
BSE: 540596 | Sector: Health care |
NSE: ERIS | ISIN Code: INE406M01024 |
BSE 00:00 | 13 Apr | 591.90 |
0.25 (0.04%) |
OPEN
596.35 |
HIGH
603.15 |
LOW
588.35 |
NSE 00:00 | 13 Apr | 592.70 |
0.65 (0.11%) |
OPEN
591.15 |
HIGH
603.00 |
LOW
587.00 |
OPEN | 596.35 |
PREVIOUS CLOSE | 591.65 |
VOLUME | 3062 |
52-Week high | 644.00 |
52-Week low | 400.00 |
P/E | 23.90 |
Mkt Cap.(Rs cr) | 8,038 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
ERIS Lifesciences Ltd. (ERIS) - Half Yearly Result
Particulars (![]() |
Sep '20 | Mar '20 | Sep '19 | Mar '19 | Sep '18 |
Net Sales/Income From Operations | 564.85 | 485.01 | 535.23 | 429.23 | 467.31 |
Other Income | 3.82 | 7.11 | 7.62 | 21.75 | 10.75 |
Total Income | 568.67 | 492.12 | 542.84 | 450.99 | 478.05 |
Total Expenditure | 344.90 | 336.98 | 327.65 | 276.71 | 286.17 |
Operating Profit | 223.77 | 155.14 | 215.19 | 174.28 | 191.88 |
Interest | 0.41 | 0.60 | 1.25 | 9.48 | 13.32 |
Gross Profit | 223.36 | 154.54 | 213.94 | 164.80 | 178.57 |
Depreciation | 18.27 | 24.31 | 20.57 | 18.43 | 13.16 |
PBT | 205.09 | 130.22 | 193.37 | 146.37 | 165.41 |
Tax | 36.21 | 23.19 | 34.30 | 32.41 | 36.46 |
Net Profit/(Loss) | 192.62 | 117.78 | 173.49 | 131.29 | 154.09 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 192.62 | 117.78 | 173.49 | 131.29 | 154.09 |
Equity Share Capital | 13.58 | 13.58 | 13.75 | 13.75 | 13.75 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 14.19 | 8.67 | 12.62 | 9.55 | 11.20 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for ERIS Lifesciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices